|
Issue |
Title |
|
Vol 7, No 1 (2020) |
In-silico interactions of active Phytochemicals with c-MYC EGFR and ERBB2 oncoproteins |
Abstract
|
Vaishali Chandel, Mitul Srivastava, Ashutosh Srivastava, Shailendra Asthana, Dhruv Kumar |
|
Vol 2, No 1 (2015) |
Evaluation of inhibition of protein tyrosine phosphatase 1B by calixarene-based α-ketophosphonic acids |
Abstract
|
Viacheslav Trush, Sergiy Cherenok, Vsevolod Tanchuk, Vitaly Kalchenko, Andriy Vovk |
|
Vol 7, No 4 (2020) |
Novel 5-Nitro Isatin derivatives as DNA Gyrase inhibitors: synthesis, anti-microbial evaluation, molecular docking, ADMET predictions and QSAR studies |
Abstract
|
walaa S El-serwy, Neama A Mohamed, Emad M. M Kassem, Eman S Nossier, Al Shimaa G Shalaby |
|
Vol 7, No 3 (2020) |
In silico identification of potent FDA approved drugs against Coronavirus COVID-19 main protease: A drug repurposing approach |
Abstract
PDF
|
Dhruv Kumar, Vaishali Chandel, Sibi Raj, Brijesh Rathi |
|
Vol 8, No 1 (2021) |
Identification of potential CYP51 inhibiting anti-Aspergillus phytochemicals using molecular docking and ADME/T studies |
Abstract
|
Mansi Shrivastava, Poonam Sharma, Rambir Singh |
|
Vol 1, No 2 (2014) |
3D-QSAR and molecular docking studies of ATP-competitive Akt inhibitors with the scaffold 4-(piperazin-1-yl)pyrimidine |
Abstract
|
Xie Wencheng, Zhang Linna, Yin Yanzhen, Yang Dezhi, Zhao Guisen |
|
1 - 6 of 6 Items |
|